Agilent Launches Online Microarray Tool and the First Commercial Human CpG Island Microarray

Agilent Technologies Inc. (NYSE: A) continues to expand its portfolio of microarrays for emerging applications by introducing the first commercial CpG Island microarrays for studying DNA methylation, an epigenetic modification known to play a significant role in many important cellular processes.

Source: Agielnt Technologies